User profiles for Fiona Havers
 | Fiona HaversMedical Officer, Division of Viral Diseases, Centers for Disease Control and Prevention Verified email at cdc.gov Cited by 7303 |
Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020
Importance Reported cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection likely underestimate the prevalence of infection in affected communities. Large-…
infection likely underestimate the prevalence of infection in affected communities. Large-…
[HTML][HTML] Risk factors for severe COVID-19 in children
…, K Patel, M Whitaker, M McMorrow, F Havers - …, 2022 - publications.aap.org
OBJECTIVES Describe population-based rates and risk factors for pediatric severe coronavirus
disease 2019 (COVID-19) (ie, ICU admission, invasive mechanical ventilation, or death). …
disease 2019 (COVID-19) (ie, ICU admission, invasive mechanical ventilation, or death). …
[PDF][PDF] Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
Importance Case-based surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection likely underestimates the true prevalence of infections. Large-scale …
infection likely underestimates the true prevalence of infections. Large-scale …
COVID-19-associated hospitalizations among vaccinated and unvaccinated adults 18 years or older in 13 US States, January 2021 to April 2022
FP Havers, H Pham, CA Taylor, M Whitaker… - JAMA internal …, 2022 - jamanetwork.com
Importance Understanding risk factors for hospitalization in vaccinated persons and the
association of COVID-19 vaccines with hospitalization rates is critical for public health efforts to …
association of COVID-19 vaccines with hospitalization rates is critical for public health efforts to …
[HTML][HTML] Hospitalization of adolescents aged 12–17 years with laboratory-confirmed COVID-19—COVID-NET, 14 states, March 1, 2020–April 24, 2021
FP Havers - MMWR. Morbidity and Mortality Weekly Report, 2021 - cdc.gov
COVID-19 adolescent hospitalization rates from COVID-NET peaked at 2.1 per 100,000 in
early January 2021, declined to 0.6 in mid-March, and rose to 1.3 in April. Among hospitalized …
early January 2021, declined to 0.6 in mid-March, and rose to 1.3 in April. Among hospitalized …
Racial and ethnic disparities in rates of COVID-19–associated hospitalization, intensive care unit admission, and in-hospital death in the United States from March …
Importance Racial and ethnic minority groups are disproportionately affected by COVID-19.
Objectives To evaluate whether rates of severe COVID-19, defined as hospitalization, …
Objectives To evaluate whether rates of severe COVID-19, defined as hospitalization, …
Outpatient antibiotic prescribing for acute respiratory infections during influenza seasons
Importance Acute respiratory infections (ARIs) are the syndrome for which antibiotics are
most commonly prescribed; viruses for which antibiotics are ineffective cause most ARIs. …
most commonly prescribed; viruses for which antibiotics are ineffective cause most ARIs. …
Outbreak of variant influenza A (H3N2) virus in the United States
…, A Greenbaum, L Gubareva, F Havers… - Clinical infectious …, 2013 - academic.oup.com
Background. Variant influenza virus infections are rare but may have pandemic potential if
person-to-person transmission is efficient. We describe the epidemiology of a multistate …
person-to-person transmission is efficient. We describe the epidemiology of a multistate …
[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …
FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix (GlaxoSmithKline)
is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi Pasteur) …
is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi Pasteur) …
Clinical trends among US adults hospitalized with COVID-19, March to December 2020: a cross-sectional study
Background: The COVID-19 pandemic has caused substantial morbidity and mortality. Objective:
To describe monthly clinical trends among adults hospitalized with COVID-19. Design: …
To describe monthly clinical trends among adults hospitalized with COVID-19. Design: …